Tobacco Use Cessation Clinical Trial
— POPMIX-SmokingOfficial title:
Population Medicine Multimorbidity Interventions in Xishui on High-risk COPD Smokers: A Cluster Randomized Controlled Trial
Study Participants: In our study, we focus on smokers who self-report a "current smoking" status or smoking cessation less than 6 months. This trial is a sub-trial of "Impact of Multi-Component Interventions on a High-Risk COPD population" (Protocol ID: CAMS&PUMC-IEC-2024-040). All smokers in this trial are either from the high-risk COPD population (defined by COPD-SQ score≥16) . Intervention: For study participants in the intervention arm, we will ask them to finish an online COPD-SQ questionnaire with notification of his or her COPD high risk. For those whose score of COPD-SQ ≥ 16, we will provide a face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline. For smokers in the intervention arm, we provide a digital health intervention program, NicQuit, to whom could familiarly use intelligent mobile phones, and health education for all smokers. We also provide community-based spirometry pulmonary function test (PFT) and education to smokers. If smokers whose post-bronchodilator FEV1/FVC<0.7, they will be spirometry-defined COPD patients and will be encouraged to seek treatment and medication to the superior hospitals. Additionally, we provide (1) another digital health intervention programs to smokers with mental health issues; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program in China for those with abnormal blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3 (telephone interview), month 6 (face-to-face with full steps of physical examination), and month 12. Comparison: Those who are assigned in the control arm, we will ask them to finish the same COPD-SQ online questionnaire with notification of his or her COPD high risk status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given. Outcomes: The primary outcomes are self-reported average number of cigarettes consumed per day, smoking dependence index, and CO measurement.
Status | Not yet recruiting |
Enrollment | 7400 |
Est. completion date | October 1, 2025 |
Est. primary completion date | September 15, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years and older |
Eligibility | Inclusion Criteria: - Aged 35 and above; - High-risk COPD population defined by the score of COPD-SQ = 16; - Self-report currently smoking or smoking cessation less than 6 month; - Local residents who stay within a township in the previous 3 months and plan to stay within the same township for the next 12 months. Exclusion Criteria: - Those who suffer from severe cognitive disorder or total loss of ability of daily living. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Peking Union Medical College | China-Japan Friendship Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Amount of smoking | Definition: Average number of cigarettes smoked per day; Variable type: Continuous; Measurement: Respondent's answer to the question. | 1 year | |
Primary | Smoking Dependence | Definition: A scale that measures the degree of smoking dependence; Variable type: Continuous; Measurement: Respondent's answer to the question. Introduction to Smoking Dependence Scale: Chinese version of Fagerström test for nicotine dependence (FTND), ranging from 0 to 15, the higher the score, the severer nicotine dependence will be. Also Heaviness of Smoking Index (HSI) will also be measured, ranging from 0 to 6, the higher the score, the worsen the nicotine dependence will be | 1 year | |
Primary | Carbon Monoxide Measurement | Definition: CO measurement by the portable CO machines Variable type: Continuous; Measurement: CO detector. | 1 year | |
Secondary | Self-rate health status | Definition: General self-assessed health status; Variable type: Continuous; Measurement: EQ-5D scale; Introduction to EQ-5D-5L scale: The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group in 2009 to improve the instrument's sensitivity and to reduce ceiling effects, as compared to the EQ-5D-3L. The scale could be transferred to health utility value, ranging from 0 to 1 continuously. 0 represents death and 1 represents perfect health. | 1 year | |
Secondary | Number of Chronic Conditions Controlled | Definition: Among 7 objectively measured health conditions (COPD, asthma, depression symptoms, anxiety symptoms, BMI, hypertension, type 2 diabetes), the number of chronic conditions controlled; Variable type: Counting data; Measurement: Through objective physical examination or validated scale; | 1 year | |
Secondary | Physical proof of cigarettes | Definition: Can you show me your cigarettes? Variable type: Binary; Measurement: Self-report questions and to let respondents show to our field workers whether he or she brings cigarettes. | 1 year | |
Secondary | FEV1 measurement | Definition: Forced Expiratory Volume in one second (FEV1); Variable type: Continuous; Measurement: Pulmonary function test, portable spirometry; | 1 year | |
Secondary | COPD Screening | Definition: Have you ever had a pulmonary function test?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Self-awareness of COPD | Definition: Have you ever been diagnosed with COPD?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | COPD-Knowledge | Definition: COPD Knowledge Questionnaire; Variable type: Continuous; Measurement: Respondent's answer to the questions; | 1 year | |
Secondary | Treatment adherence | Definition: Are you currently receiving a COPD treatment plan prescribed by a doctor or other healthcare professional?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | COPD control | Definition: Has the number of acute exacerbations decreased in the past six months?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Blood pressure | Definition: Systolic and diastolic blood pressure (mmHg); Variable type: Continuous; Measurement: Omron portable automatic blood pressure monitor; | 1 year | |
Secondary | Blood Glucose | Definition: Reference standard for average plasma glucose concentration over a period of time; Variable type: Continuous; Measurement: Blood glucose meter; | 1 year | |
Secondary | Waist circumference | Definition: Waist circumference (cm); Variable type: Continuous; Measurement: Soft measuring tape; | 1 year | |
Secondary | BMI | Definition: Body mass index (BMI), weight divided by height squared (kg/m²); Variable type: Continuous; Measurement: Calculation; | 1 year | |
Secondary | Number of Outpatient Visits | Definition: Outpatient visits and type of hospital; Variable type: Count; Measurement: Insurance/outpatient data; | 1 year | |
Secondary | Number of Inpatient Visits | Definition: Inpatient visits and type of hospital; Variable type: Count; Measurement: Insurance/inpatient data; | 1 year | |
Secondary | Medical expenditure within a family over the past year | Definition: Healthcare-related expenditures; Variable type: Continuous; Measurement: Insurance/outpatient/inpatient data; | 1 year | |
Secondary | Depression Symptoms | Definition: Emotional disorders, including sadness, loss, and anger; Variable type: Continuous; Measurement: PHQ-9; Introduction to PHQ-9: Patient Health Questionnaire- 9 items (PHQ-9), ranging from 0 to 27, the higher the score, the severer the depression symptoms for the respondents will be. | 1 year | |
Secondary | Anxiety Symptoms | Definition: Unpleasant state of inner turmoil; Variable type: Continuous; Measurement: GAD-7; Introduction to GAD-7: General Anxiety Disorder - 7 (GAD-7), ranging from 0 to 21, the higher the score, the severer the anxiety symptoms for the respondents will be. | 1 year | |
Secondary | Warwick-Edinburgh Mental Well-being Scale, WEM -WBS | Definition: Reflects overall mental health problems; Variable type: Continuous; Measurement: WEMWBS; Introduction to WEMWBS: Warwick-Edinburgh Mental Well-being Scale, ranging from 14 to 70, the lower the score, the worse one's general mental health will be. | 1 year | |
Secondary | Productivity Loss | Definition: Productivity loss due to illness or health problems; Variable type: Continuous; Measurement: Respondent's answer to the question;
Introduction to WPAI-GH : Work Productivity and Activity Impairment-General Health (v2.0) Chinese version.WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity, i.e., worse outcomes, as follows: Questions: = currently employed = hours missed due to health problems = hours missed other reasons = hours actually worked = degree health affected productivity while working = degree health affected regular activities Scores: Multiply scores by 100 to express in percentages. Percent work time missed due to health: Q2/(Q2+Q4) Percent impairment while working due to health: Q5/10 Percent overall work impairment due to health: Q2/(Q2+Q4)+[(1-(Q2/(Q2+Q4)))x(Q5/10)] Percent activity impairment due to health: Q6/10 |
1 year | |
Secondary | HBP Screening | Definition: Have you ever had your blood pressure measured by a doctor, nurse, or other healthcare professional?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | HBP Diagnosis | Definition: Have you ever been diagnosed with hypertension by a doctor?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | HBP Treatment | Definition: Are you currently taking any antihypertensive medication prescribed by a doctor or other healthcare professional? ; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | HBP Control | Definition: Blood pressure within the normal range at the end-of-year follow-up; Variable type: Binary; Measurement: Blood pressure measurement; | 1 year | |
Secondary | T2DM Screening | Definition: Have you ever had your blood glucose measured by a doctor, nurse, or other healthcare professional?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | T2DM Diagnosis | Definition: Have you ever been diagnosed with T2DM by a doctor?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | T2DM Treatment | Definition: Are you currently receiving a type 2 diabetes treatment plan prescribed by a doctor or other healthcare professional?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | T2DM Control | Definition: Blood glucose within the normal range at the end-of-year follow-up; Variable type: Binary; Measurement: Blood glucose measurement; | 1 year | |
Secondary | Smoking Status | Definition: Do you currently smoke?; Variable type: Binary; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Drinking Status | Definition: Frequency of alcohol consumption in the past 3 months; Variable type: Categorical; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Sugar Consumption | Definition: Frequency of consumption of sugary foods/drinks; Variable type: Categorical; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Salted Vegetables Consumption | Definition: Frequency of consumption of salty vegetables; Variable type: Categorical; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Vegetable Consumption | Definition: Frequency of consumption of vegetable; Variable type: Categorical; Measurement: Respondent's answer to the question; | 1 year | |
Secondary | Physical exercise | Definition: Hours of physical exercise per week; Variable type: Count; Measurement: Respondent's answer to the question; | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021652 -
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
|
N/A | |
Completed |
NCT02735382 -
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
|
N/A | |
Completed |
NCT02557919 -
Families Reduce Exposure to Smoke at Home
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT00786149 -
Improving Varenicline Adherence and Outcomes in Homeless Smokers
|
Phase 3 | |
Completed |
NCT00387946 -
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
|
Phase 3 | |
Completed |
NCT00218452 -
Smoking Cessation for Young Adults Who Binge Drink - 1
|
Phase 0 | |
Completed |
NCT00124683 -
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
|
Phase 2 | |
Recruiting |
NCT04610931 -
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Recruiting |
NCT04994444 -
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
|
Phase 2/Phase 3 | |
Recruiting |
NCT04827420 -
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
|
N/A | |
Completed |
NCT05560243 -
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
|
N/A | |
Completed |
NCT02721082 -
Changing the Default for Tobacco Treatment
|
Phase 4 | |
Completed |
NCT01885221 -
A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
|
N/A | |
Completed |
NCT03445507 -
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
|
N/A | |
Completed |
NCT04540081 -
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
|
N/A | |
Completed |
NCT03714191 -
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
|
||
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Completed |
NCT01699828 -
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
|
Phase 1/Phase 2 |